Icon

ZORTRESS (nda021560)- (0.25MG,0.5MG,0.75MG,1MG)

EVEROLIMUS NOVARTIS
0.25MG,0.5MG,0.75MG,1MG
Yes No
2020-Mar-09 2014-Mar-30
None 2013-Apr-20
None No
Zortress is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients:  Kidney Transplant: at low-moderate immunologic risk. Use in combination with basiliximab, cyclosporine (reduced doses) and corticosteroids.  Liver Transplant: Administer no earlier than 30 days post-transplant. Use in combination with tacrolimus (reduced doses) and corticosteroids.
4 0 4
Total Other Developers 11
Drugs with Suitability No
0.25MG ** ** - - 4
0.5MG ** ** - 4 -
0.75MG ** ** - - 4
1MG ** ** - - 3
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ************ ***** ****** ******* *********** ****** ********, ******, **********, ********* *** ***, ***** (***) ***
****** ***** ****-**** ******** ***. *********** **** ****** ****, ********, **** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.